Pfizer/BioNTech say booster dose increases protection against Omicron in kids aged 5-11 | Reuters
A third dose of Pfizer Inc and BioNTech's COVID vaccine produced significant protection against the Omicron variant in healthy children aged between 5 and 11 years in a trial, the companies said on Thursday.